Drug Profile
Research programme: anti-interleukin-13 monoclonal antibodies - Centocor
Alternative Names: Anti-IL-13 monoclonal antibodies - Centocor; Anti-interleukin-13 monoclonal antibodies research programme - CentocorLatest Information Update: 13 Mar 2008
Price :
$50
*
At a glance
- Originator Centocor
- Class Monoclonal antibodies
- Mechanism of Action Interleukin 13 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 22 Jun 2004 Preclinical trials in Asthma in USA (unspecified route)